Evidence map›Paper›PMID 36005272›Full record

ArticleAmerican journal of men's health

Predictors of Anal High-Risk HPV Infection Across Time in a Cohort of Young Adult Sexual Minority Men and Transgender Women in New York City, 2015-2020.

Caleb LoSchiavo, Paul A D'Avanzo, Connor Emmert, Kristen D Krause, Danielle C Ompad, Farzana Kapadia, Perry N Halkitis

Open access · goldAbstract read
In one paragraph

Article in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Caleb LoSchiavoCenter for Health, Identity, Behavior & Prevention Studies (CHIBPS), Rutgers School of Public Health, Piscataway, NJ, USA.ORCID 0000-0001-7631-6405
Paul A D'AvanzoCenter for Health, Identity, Behavior & Prevention Studies (CHIBPS), Rutgers School of Public Health, Piscataway, NJ, USA.
Connor EmmertCenter for Health, Identity, Behavior & Prevention Studies (CHIBPS), Rutgers School of Public Health, Piscataway, NJ, USA.
Kristen D KrauseCenter for Health, Identity, Behavior & Prevention Studies (CHIBPS), Rutgers School of Public Health, Piscataway, NJ, USA.
Danielle C OmpadDepartment of Epidemiology, School of Global Public Health, New York University, New York City, USA.
Farzana KapadiaDepartment of Epidemiology, School of Global Public Health, New York University, New York City, USA.
Perry N HalkitisCenter for Health, Identity, Behavior & Prevention Studies (CHIBPS), Rutgers School of Public Health, Piscataway, NJ, USA.
Rutgers, The State University of New Jersey · USNew York University · US

Funding

INSPIRE : Interdisciplinary Social and Behavioral Science Prevention and Intervention REsearch in HIVT32MH019139 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Claude Ann Mellins, Jae M. Sevelius · 1989 to 2026
$10.8M
Syndemic Production in Emergent Adult MenR01DA025537 · NIDA · RBHS-SCHOOL OF PUBLIC HEALTH · PI HALKITIS, PERRY N · 2009 to 2018
$6.0M
Application of a syndemic framework to HPV and HSV infection in emergent adult menR01AI132020 · NIAID · NEW YORK UNIVERSITY · PI HALKITIS, PERRY N, KAPADIA, FARZANA · 2017 to 2019
$2.3M
Application of a syndemic framework to HPV and HSV infection in emergent adult menR56AI122000 · NIAID · NEW YORK UNIVERSITY · PI HALKITIS, PERRY N, KAPADIA, FARZANA · 2015 to 2015
$584k
NIAID NIH HHS R01 AI132020NIAID NIH HHS R56 AI122000NIDA NIH HHS R01 DA025537NIMH NIH HHS T32 MH019139
6 · The paper itself

Abstract

Cisgender sexual minority men (SMM) and transgender women are disproportionately vulnerable to HPV-related anal cancer, but little is known about longitudinal predictors of high-risk human papillomavirus (hrHPV) infection in this population. As such, this analysis aims to identify factors associated with incident anal hrHPV infection in a diverse cohort of young SMM and transgender women. This study of HPV infection, nested within a larger cohort study, took place between October 2015 and January 2020. Participants completed a brief computer survey assessing HPV symptomatology, risk, and prevention alongside multi-site testing, in addition to biannual cohort study assessments. In the analytic sample of 137 participants, 31.6% tested positive for an anal hrHPV infection, with 27.0% and 29.9% testing positive for incident anal hrHPV infections at Visits 2 and 3, respectively. When adjusting for time between study visits, participants had significantly greater odds of incident anal hrHPV at Visit 2 if they had a concurrent HSV infection (AOR = 5.08 [1.43, 18.00]). At Visit 3, participants had significantly greater odds of incident anal hrHPV infection if they reported a greater number of sex partners in the previous month (AOR = 1.25 [1.03, 1.51]). Prevalence of cancer-causing HPV at baseline was high and many participants tested positive for additional types of anal hrHPV at subsequent visits. Risk for newly detected anal hrHPV infection was significantly associated with biological and behavioral factors. Our findings strongly indicate a need for programs to increase uptake of HPV vaccination and provide HPV-related health education for sexual and gender minorities.

Indexed as

Papillomavirus InfectionsSexual and Gender MinoritiesTransgender PersonsCohort StudiesFemaleHomosexuality, MaleHumansMaleNew York CityPapillomaviridaePrevalenceRisk FactorsYoung Adultanal cancerHPVhuman papillomavirusLGBTQ healthmen who have sex with men

Identifiers

PMID36005272
PMCPMC9421230
OpenAlexW4293092117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.